| The human cerebellum T Roostaei, A Nazeri, MA Sahraian, A Minagar Neurologic clinics 32 (4), 859-869, 2014 | 176 | 2014 |
| Neuropathological correlates and genetic architecture of microglial activation in elderly human brain D Felsky, T Roostaei, K Nho, SL Risacher, EM Bradshaw, V Petyuk, ... Nature communications 10 (1), 409, 2019 | 145 | 2019 |
| Gray matter neuritic microstructure deficits in schizophrenia and bipolar disorder A Nazeri, BH Mulsant, TK Rajji, ML Levesque, J Pipitone, L Stefanik, ... Biological psychiatry 82 (10), 726-736, 2017 | 101 | 2017 |
| Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) A Eshaghi, S Riyahi-Alam, T Roostaei, G Haeri, A Aghsaei, MR Aidi, ... The Clinical Neuropsychologist 26 (6), 975-984, 2012 | 81 | 2012 |
| Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial S Bitarafan, A Saboor-Yaraghi, MA Sahraian, D Soltani, S Nafissi, ... Iranian Journal of Allergy, Asthma and Immunology, 13-19, 2016 | 75 | 2016 |
| Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer’s disease T Roostaei, A Nazeri, D Felsky, PL De Jager, JA Schneider, BG Pollock, ... Molecular psychiatry 22 (2), 287-295, 2017 | 71 | 2017 |
| Impact of vitamin A supplementation on disease progression in patients with multiple sclerosis S Bitarafan, A Saboor-Yaraghi, MA Sahraian, S Nafissi, M Togha, ... Archives of Iranian Medicine 18 (7), 0-0, 2015 | 51 | 2015 |
| The effect of vitamin A supplementation on FoxP3 and TGF-β gene expression in Avonex-treated multiple sclerosis patients AA Saboor-Yaraghi, MH Harirchian, N Mohammadzadeh Honarvar, ... Journal of molecular neuroscience 56, 608-612, 2015 | 48 | 2015 |
| Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis A Eshaghi, S Riyahi-Alam, R Saeedi, T Roostaei, A Nazeri, A Aghsaei, ... NeuroImage: Clinical 7, 306-314, 2015 | 48 | 2015 |
| Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease A Nazeri, H Ganjgahi, T Roostaei, T Nichols, M Zarei, ... Neuroimage 102, 657-665, 2014 | 32 | 2014 |
| Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis T Roostaei, S Sadaghiani, MTM Park, R Mashhadi, A Nazeri, S Noshad, ... Neurology 86 (5), 410-417, 2016 | 26 | 2016 |
| Impact of melatonin on motor, cognitive and neuroimaging indices in patients with multiple sclerosis T Roostaei, MA Sahraian, S Hajeaghaee, T Gholipour, M Togha, B Siroos, ... Iranian Journal of Allergy, Asthma and Immunology, 589-595, 2015 | 25 | 2015 |
| Genetic influence of plasma homocysteine on Alzheimer's disease T Roostaei, D Felsky, A Nazeri, PL De Jager, JA Schneider, DA Bennett, ... Neurobiology of aging 62, 243. e7-243. e14, 2018 | 23 | 2018 |
| Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome T Roostaei, HU Klein, Y Ma, D Felsky, P Kivisäkk, SM Connor, ... Nature communications 12 (1), 7078, 2021 | 22 | 2021 |
| Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis T Roostaei, S Sadaghiani, R Mashhadi, M Falahatian, E Mohamadi, ... Multiple Sclerosis Journal 25 (4), 532-540, 2019 | 22 | 2019 |
| Genome‐wide variant by serum urate interaction in Parkinson's disease A Nazeri, T Roostaei, S Sadaghiani, MM Chakravarty, S Eberly, AE Lang, ... Annals of neurology 78 (5), 731-741, 2015 | 11 | 2015 |
| Defining the architecture of cerebrospinal fluid cellular communities in neuroinflammatory diseases T Roostaei, C Diaconu, H Touil, C Harbison, Y Zhang, S Epstein, ... bioRxiv, 2021.11. 01.466797, 2021 | 9 | 2021 |
| A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis S Peroni, M Sorosina, S Malhotra, F Clarelli, AM Osiceanu, L Ferrè, ... Multiple Sclerosis Journal 26 (9), 1074-1082, 2020 | 9 | 2020 |
| A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization JF Tuddenham, M Taga, V Haage, T Roostaei, C White, A Lee, M Fujita, ... bioRxiv, 2022.06. 04.494709, 2022 | 3 | 2022 |
| Part II Multiple Sclerosis: Epidemiology and Genetics T Roostaei, PL De Jager Clinical Neuroimmunology, 71-87, 2020 | 3* | 2020 |
